Clamp, A., McNeish, I., Dean, A., Gallardo, D., Weon-Kim, J., O'Donnell, D., . . . Ledermann, J. (2017). ICON8: A GCIG phase III randomised trial evaluating weekly dosedense chemotherapy integration in first- line epithelial ovarian/fallopian tube/primary peritoneal carcinoma (EOC) treatment: Results of primary progression- free survival (PFS) analysis. Oxford University Press.
Chicago Style (17th ed.) CitationClamp, A., et al. ICON8: A GCIG Phase III Randomised Trial Evaluating Weekly Dosedense Chemotherapy Integration in First- Line Epithelial Ovarian/fallopian Tube/primary Peritoneal Carcinoma (EOC) Treatment: Results of Primary Progression- Free Survival (PFS) Analysis. Oxford University Press, 2017.
MLA引文Clamp, A., et al. ICON8: A GCIG Phase III Randomised Trial Evaluating Weekly Dosedense Chemotherapy Integration in First- Line Epithelial Ovarian/fallopian Tube/primary Peritoneal Carcinoma (EOC) Treatment: Results of Primary Progression- Free Survival (PFS) Analysis. Oxford University Press, 2017.